Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

Assessing Patients Preferences Towards Disease-modifying Therapeutic Options in Relapsing Remitting Multiple Sclerosis

This multi-center non-interventional, observational, cross-sectional study in adult participants with relapsing remitting multiple sclerosis (RRMS) will evaluate the participants' preferences for disease modifying treatments (DMT) in routine clinical practice.

Inclusion Criteria:

• Participants aged greater than or equal to (>/=) 18 years
• Participants who have a diagnosis of RRMS as documented in their medical records
• Participants who have been prescribed a DMT for at least 3 months
• Participants who have an expanded disability status scale (EDSS) score of 1-6 points

Exclusion Criteria:

- Participants with any personal or medical condition that in opinion of the investigator would interfere with or make impossible proper participation in the study